Advertisement
Advertisement

SIBN

SIBN logo

SI-BONE, Inc. Common Stock

18.80
USD
Sponsored
-0.04
-0.21%
Aug 11, 16:00 UTC -4
Closed
exchange

Pre-Market

18.80

0.00
0.00%

SIBN Earnings Reports

Positive Surprise Ratio

SIBN beat 21 of 32 last estimates.

66%

Next Report

Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$56.42M
/
-$0.13
Implied change from Q2 26 (Revenue/ EPS)
+0.74%
/
+44.44%
Implied change from Q3 25 (Revenue/ EPS)
+15.96%
/
+18.18%

SI-BONE, Inc. Common Stock earnings per share and revenue

On Aug 03, 2026, SIBN reported earnings of -0.09 USD per share (EPS) for Q2 26, beating the estimate of -0.15 USD, resulting in a 41.02% surprise. Revenue reached 56.01 million, compared to an expected 56.44 million, with a -0.76% difference. The market reacted with a -0.05% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of -0.13 USD, with revenue projected to reach 56.42 million USD, implying an increase of 44.44% EPS, and increase of 0.74% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Tactile Systems Technology, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.14
Actual
$0.34
Surprise
+131.45%
logo
Mesa Laboratories Inc
Report Date
Aug 10, 2026 For Q1 27
Estimate
$0.03
Actual
$2.61
Surprise
+8,429.41%
logo
Mobia Medical, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.65
Actual
-$0.88
Surprise
-33.41%
logo
908 Devices Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.17
Actual
-$0.11
Surprise
+36.56%
logo
Treace Medical Concepts, Inc. Common Stock
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$0.30
Actual
-$0.24
Surprise
+21.05%
logo
Neuronetics, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.12
Actual
-$0.05
Surprise
+60.00%
logo
Stereotaxis, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
logo
Xtant Medical Holdings, Inc.
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.07
Surprise
-243.14%
logo
Spectral AI, Inc. Class A Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.13
Surprise
+5.59%
logo
DarioHealth Corp. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$1.23
Actual
-$0.56
Surprise
+54.01%
FAQ
For Q2 2026, SI-BONE, Inc. Common Stock reported EPS of -$0.09, beating estimates by 41.02%, and revenue of $56.01M, -0.76% below expectations.
The stock price moved down -0.05%, changed from $18.45 before the earnings release to $18.44 the day after.
The next earning report is scheduled for Nov 09, 2026.
Based on 10 analysts, SI-BONE, Inc. Common Stock is expected to report EPS of -$0.13 and revenue of $56.42M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement